<SEC-DOCUMENT>0000930413-19-000983.txt : 20190320
<SEC-HEADER>0000930413-19-000983.hdr.sgml : 20190320
<ACCEPTANCE-DATETIME>20190320160537
ACCESSION NUMBER:		0000930413-19-000983
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190314
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190320
DATE AS OF CHANGE:		20190320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COLGATE PALMOLIVE CO
		CENTRAL INDEX KEY:			0000021665
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				131815595
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00644
		FILM NUMBER:		19694711

	BUSINESS ADDRESS:	
		STREET 1:		300 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		2123102000

	MAIL ADDRESS:	
		STREET 1:		300 PARK AVE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c93240_8k.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Washington,
DC</B></FONT><B> 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of earliest event reported)</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">March 20, 2019 (March 14, 2019)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0"><B>COLGATE-PALMOLIVE COMPANY</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0">(Exact name of registrant
as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 35%; text-align: center"><FONT STYLE="font-size: 11pt"><U>Delaware</U></FONT></TD>
    <TD STYLE="width: 30%; text-align: center"><FONT STYLE="font-size: 11pt"><U>1-644</U></FONT></TD>
    <TD STYLE="width: 35%; text-align: center"><FONT STYLE="font-size: 11pt"><U>13-1815595</U></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">(State or other jurisdiction</FONT><BR>
<FONT STYLE="font-size: 11pt">of incorporation)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">(Commission</FONT><BR>
<FONT STYLE="font-size: 11pt">File Number)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">(IRS Employer</FONT><BR>
<FONT STYLE="font-size: 11pt">Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: center"><FONT STYLE="font-size: 11pt"><U>300 Park Avenue, New York, NY</U></FONT></TD>
    <TD STYLE="width: 40%; text-align: center"><FONT STYLE="font-size: 11pt"><U>10022</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 11pt">(Address of principal executive offices)</FONT></TD>
    <TD>
        <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Zip Code)</P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&rsquo;s telephone number, including area
code <U>(212) 310-2000</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (<I>see </I>General Instruction A.2. below):</FONT></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font: 11pt Wingdings; letter-spacing: -0.15pt">o</FONT></TD>
    <TD STYLE="width: 92%"><FONT STYLE="font-size: 11pt; letter-spacing: -0.15pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 11pt Wingdings; letter-spacing: -0.15pt">o</FONT></TD>
    <TD><FONT STYLE="font-size: 11pt; letter-spacing: -0.15pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 11pt Wingdings; letter-spacing: -0.15pt">o</FONT></TD>
    <TD><FONT STYLE="font-size: 11pt; letter-spacing: -0.15pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 11pt Wingdings; letter-spacing: -0.15pt">o</FONT></TD>
    <TD><FONT STYLE="font-size: 11pt; letter-spacing: -0.15pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.15pt">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; background-color: white">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405) or Rule 12b-2 of the
Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white">Emerging growth company
<FONT STYLE="font-family: MS Mincho">&#9744;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: MS Mincho">&#9744;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>I</B></FONT><B>tem
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">At the regularly scheduled March 14, 2019 meeting of the independent
Personnel and Organization Committee (the &ldquo;Committee&rdquo;) of the Board of Directors (the &ldquo;Board&rdquo;) of Colgate-Palmolive
Company (the &ldquo;Company&rdquo;), in consultation with the other independent directors of the Board, the Committee approved
the following compensatory arrangements for Noel R. Wallace in his new role as President and Chief Executive Officer of the Company,
effective April 2, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Effective April 2, 2019, Mr. Wallace&rsquo;s annual salary will
be increased from $950,000 to $1,250,000. In addition, the target awards for which Mr. Wallace is eligible under the Company&rsquo;s
regular incentive compensation programs<B> </B>will be adjusted as follows, in each case effective April 2, 2019: (i) his target
aggregate annual bonus award opportunity will be increased from 100% to 160% of his base salary; (ii) his target long-term incentive
restricted stock unit award opportunities under the Company&rsquo;s Long-Term Global Growth Program for the performance cycles
from 2017 to 2019 and from 2018 to 2020 will be increased from $1,250,000 to $3,375,000; and (iii) the guideline value of his stock
option award will be increased from $1,250,000 to $3,375,000. In addition, as part of the Company&rsquo;s overall transition of
its long-term incentive compensation program for all eligible employees, Mr. Wallace received a target award of 50,943 performance-based
restricted stock units on March 14, 2019 for the performance period from 2019 to 2021. These performance-based restricted stock
units will be earned and will vest in accordance with the form of award agreement filed as Exhibit 99 hereto following the conclusion
of the three-year performance period that ends on December 31, 2021 on the basis of the achievement of performance goals determined
by the Committee. Mr. Wallace&rsquo;s actual awards under these programs may vary from target based on performance in accordance
with the formulas and methodologies employed in the applicable programs, as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Also on March 14, 2019, the Committee, in consultation with the
other independent directors of the Board, approved the following compensatory arrangements for Ian Cook in his new role as Executive
Chairman of the Company, effective April 2, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Effective April 2, 2019, Mr. Cook&rsquo;s annual salary will remain
at $1,400,000 and his target annual bonus award opportunity will remain at 160% of his base salary. In addition, Mr. Cook&rsquo;s
long-term incentive award opportunity will be reduced from $9,250,000 to $3,610,000. Mr. Cook&rsquo;s long-term incentive award
will be paid in stock options to be granted in September in accordance with the Company&rsquo;s regular grant procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 50%"><PAGE></PAGE></TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01. Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(d)<I>&#9;Exhibits</I>. The following exhibit is filed with this
document:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; font-size: 10pt"><U>Exhibit Number</U></TD>
    <TD STYLE="width: 75%; font-size: 10pt"><U>Description</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">99</TD>
    <TD STYLE="font-size: 10pt"><A HREF="c93240_ex99.htm" STYLE="-sec-extract: exhibit">Form of Performance-Based Restricted Stock Unit Agreement for the 2019-2021 Performance Cycle</A>&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 50%"><PAGE></PAGE></TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="line-height: 115%"><B>COLGATE-PALMOLIVE COMPANY</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 115%; width: 60%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 29%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Date: March 20, 2019</TD>
    <TD COLSPAN="2">By: /s/ Jennifer M. Daniels
    <DIV ALIGN="LEFT" STYLE="margin-left: 16pt"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 100%">&nbsp;</DIV></DIV></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD COLSPAN="2">Jennifer M. Daniels</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>Title: </TD>
    <TD>Chief Legal Officer and Secretary&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 50%"><PAGE></PAGE></TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0pt"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 25%; font-size: 10pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><U>Exhibit Number</U></FONT></TD>
    <TD STYLE="width: 75%; font-size: 10pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><U>Description</U></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-indent: 0pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">99</FONT></TD>
    <TD STYLE="font-size: 10pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">Form of Performance-Based Restricted Stock Unit Agreement for the 2019-2021 Performance Cycle </FONT></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>c93240_ex99.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 99</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>COLGATE-PALMOLIVE COMPANY<BR>
2019 PERFORMANCE STOCK UNIT AWARD AGREEMENT</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 19.5pt">THIS AWARD AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;),
effective as of the date indicated on the Notice of Grant delivered herewith (the &ldquo;<U>Notice of Grant</U>&rdquo;), is made
and entered into by and between Colgate Palmolive Company, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and the individual
named on the Notice of Grant (&ldquo;<U>you</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 19.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">WITNESSETH:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">WHEREAS, the Colgate Palmolive Company 2013 Incentive
Compensation Plan (the &ldquo;<U>Plan</U>&rdquo;) provides for the grant of performance-based Restricted Stock Units, which are
referred to in this Agreement as &ldquo;<U>PBRSUs;</U>&rdquo; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">WHEREAS, the Committee has awarded to you the
PBRSUs described in the Notice of Grant, subject to the terms and conditions of this Agreement and the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">NOW, THEREFORE, in consideration of the foregoing
and of the mutual covenants and agreements herein contained, and as an inducement to you to continue as an employee of the Company
(or its Affiliates), you and the Company hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">Capitalized terms used and not otherwise defined
in this Agreement shall have the meanings set forth in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">1.<FONT STYLE="color: black"> <U>Grant of Award</U>.
</FONT>The Award consists of that number of PBRSUs that has been approved for the Award to you by the Committee as the target number
of PBRSUs, as set forth in the Notice of Grant (&ldquo;<U>Target PBRSUs</U>&rdquo;). Each PBRSU is equivalent to one Share. Your
rights to the PBRSUs are subject to this Agreement and the Plan (which is incorporated herein by reference with the same effect
as if set forth herein in full) in addition to such other terms and conditions, if any, as may be imposed by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">2. <U>Vesting of Award</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(a) <U>Vesting Upon Performance and Continued
Service</U>. The number of PBRSUs earned and vested with respect to the Performance Period (as defined in <U>Exhibit A</U>) shall
be determined based on the extent to which the performance criteria set forth in <U>Exhibit A</U> hereto (the &ldquo;<U>Performance
Criteria</U>&rdquo;) are attained. Except as otherwise provided in Section 2(b) and Section 2(c) below, if (i) the Committee certifies
in writing the extent to which the applicable Performance Criteria in the Performance Period are attained and (ii) you remain continuously
employed by the Company or an Affiliate through the date on which the Committee certifies such performance (the &ldquo;<U>Certification
Date</U>&rdquo;), you will become vested in the number of PBRSUs earned pursuant to <U>Exhibit A</U> as of the Certification Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt"><FONT STYLE="color: black">(b) <U>Termination
of Employment due to Death, Disability or Retirement</U>. Unless otherwise determined by the </FONT>Committee<FONT STYLE="color: black">,
if (i) you are employed with the Company or an Affiliate for at least six months of the Performance Period and (ii) (A) you begin
to receive</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">benefits under the Company&rsquo;s long-term disability plan, (B)
you terminate your employment with the Company or an Affiliate due to Retirement or (C) your employment with the Company or an
Affiliate terminates due to your death, in each case on or before the Certification Date, the remaining portion of the Performance
Period shall continue through its last day, and you shall become vested as of the Certification Date in a pro-rata portion of the
PBRSUs equal to the product obtained by multiplying (x) the total number of PBRSUs earned with respect to the Performance Period
based on actual performance during the Performance Period as determined in accordance with <U>Exhibit A</U> by (y) a fraction,
the numerator of which is the total number of days in the Performance Period during which you are employed by the Company or an
Affiliate (or, in the case of (A) above, the number of days during the Performance Period before you began receiving benefits under
the Company&rsquo;s long-term disability plan) and the denominator of which is the total number of days during the Performance
Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt"><FONT STYLE="color: black">(c) <U>Vesting Upon
a Change in Control</U>. The treatment of your PBRSUs in the event of a Change in Control shall be governed by Section 11 of the
</FONT>Plan<FONT STYLE="color: black">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(d) <U>Forfeiture of Unvested PBRSUs</U>. Except
as provided in Section 2(b) or Section 2(c) above, or as otherwise determined by the Committee, if your employment with the Company
or an Affiliate terminates for any reason during the Performance Period or the period after the Performance Period and before the
Certification Date, any PBRSUs will be forfeited and canceled as of the date of such termination of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(e) <U>Repayment</U>. You agree and acknowledge
that this Agreement is subject to any policies that the Committee may adopt from time to time with respect to the repayment to
the Company of any benefit received hereunder, including &ldquo;clawback&rdquo; policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">3. <U>Distribution of Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(a) <U>Distribution Upon Vesting</U>. The Company
will distribute to you (or to your estate in the event of your death) the Shares represented by the PBRSUs that are earned and
vested in accordance with Section 2 and <U>Exhibit A</U> as soon as administratively practicable, but no later than the earlier
of (i) 60 days after the Certification Date, and (ii) March 15, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(b) <U>Forfeiture of Shares; Termination for
Cause</U>. Notwithstanding any provision of this Agreement or the Plan to the contrary, if (i) your employment with the Company
or an Affiliate is terminated for Cause, or (ii) your employment with the Company or an Affiliate is terminated for any reason,
voluntarily or involuntarily, and before the Certification Date it is discovered that you engaged in conduct that would have justified
termination for Cause, your rights in your unvested PBRSUs will be immediately forfeited and canceled as of such termination date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(c) <U>Compliance With Law</U>. The Plan, the
granting and vesting of the PBRSUs, and any obligations of the Company under the Plan, shall be subject to all applicable federal,
state and foreign country laws, rules and regulations, and to such approvals by any regulatory or governmental agency as may be
required, and to any rules or regulations of any exchange on which the Shares are listed. The International Appendix hereto describes
additional terms and conditions applicable to the PBRSUs in certain foreign countries. The Company, in its</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">discretion, may postpone the vesting of the PBRSUs, the issuance
or delivery of Shares under this Award or any other action permitted under the Plan to permit the Company, with reasonable diligence,
to complete such stock exchange listing or registration or qualification of such Shares or other required action under any federal,
state or foreign country law, rule or regulation and may require you to make such representations and furnish such information
as it may consider appropriate in connection with the issuance or delivery of Shares in compliance with applicable laws, rules
and regulations. The Company shall not be obligated by virtue of any provision of the Plan to recognize the vesting of the PBRSUs
or to otherwise sell or issue Shares in violation of any such laws, rules or regulations. Neither the Company nor its directors
or officers shall have any obligation or liability to you caused by any postponement of the vesting or settlement of the PBRSUs
(or Shares issuable thereunder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">4. <U>No Stockholder Rights</U>. Except as set
forth in the Plan, neither you nor any person claiming under or through you shall be, or have any of the rights or privileges of,
a stockholder of the Company (<I>e.g.,</I> you have no right to vote or receive dividends) in respect of the Shares issuable pursuant
to this Award unless and until your Shares shall have been issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"><FONT STYLE="color: black">5. <U>Tax Withholding</U>.
</FONT>No later than the date as of which an amount first becomes includible in your gross income for federal, state, local or
foreign tax purposes with respect to this Award, you shall pay to the Company, or make arrangements satisfactory to the Company
regarding the payment of, any federal, state, local or foreign taxes of any kind required by law to be withheld with respect to
such amount. Unless otherwise determined by the Company, withholding obligations may be settled with Common Stock, including Common
Stock that is part of this Award that gives rise to the withholding requirement, having a Fair Market Value on the date of withholding
equal to the amount required to be withheld for tax purposes, all in accordance with any such procedures as the Committee may establish.
The obligations of the Company under this Agreement shall be conditional on such payment or arrangements, and the Company and its
Affiliates shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to you.
The Committee may establish such procedures as it deems appropriate, including making irrevocable elections, for the settlement
of withholding obligations with Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">6. <U>PBRSUs Not Transferable</U>. The PBRSUs
granted herein are not transferable except in accordance with the provisions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">7. <U>Plan Incorporated</U>. You accept the PBRSUs
hereby granted subject to all the provisions of the Plan, which are incorporated into this Agreement, including the provisions
that authorize the Committee to administer and interpret the Plan and which provide that the Committee&rsquo;s decisions, determinations
and interpretations with respect to the Plan are final and conclusive on all persons affected thereby. In the event of a conflict
between this Agreement and the Plan, the Plan shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">8. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(a) <U>No Guaranteed Employment</U>. Nothing
contained in this Agreement shall affect the right of the Company or an Affiliate to terminate your employment at any time, with
or</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">without Cause, or shall be deemed to create any rights to employment
on your part. The rights and obligations arising under this Agreement are not intended to and do not affect the employment relationship
that otherwise exists between the Company or an Affiliate and you, whether such employment relationship is at will or defined by
an employment contract. Moreover, this Agreement is not intended to and does not amend any existing employment contract between
the Company and you. To the extent there is a conflict between this Agreement and such an employment contract as it relates to
the PBRSUs awarded hereunder, the terms of this Agreement shall govern and take priority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(b) <U>Notices</U>. Any notice to be given to
the Company under the terms of this Agreement shall be addressed to the Secretary at the Company&rsquo;s principal executive offices,
and any notice to be given to you shall be addressed to you at the address on file with the Company and/or the Company&rsquo;s
plan administrator, Merrill, Lynch, Pierce, Fenner&nbsp;&amp; Smith Incorporated (&ldquo;<U>Merrill</U>&rdquo;). Either the Company
or you may designate a different address by written notice to the other. Written notice to said addresses shall be effective to
bind the Company, you and your representatives and beneficiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(c) <U>Binding Agreement</U>. Subject to the
limitations in this Agreement on the transferability by you of the Award granted herein, this Agreement shall be binding upon and
inure to the benefit of the representatives, executors, successors or beneficiaries of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(d) <U>Governing Law; Jurisdiction</U>. The interpretation,
performance and enforcement of this Agreement shall be governed by the laws of the State of Delaware and the United States, as
applicable, without reference to the conflict of laws provisions thereof. Any disputes involving this Award Agreement or the related
Restricted Stock Unit Award will be heard and determined before the Delaware Court of Chancery or if not maintainable therein,
then before an appropriate federal or state court located in Delaware, and you and the Company each agree to submit yourself and
your respective property to the non-exclusive jurisdiction of the foregoing courts with respect to such disputes, in each case,
as permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(e) <U>Severability</U>. If any provision of
this Agreement is declared or found to be illegal, unenforceable or void, in whole or in part, then the parties shall be relieved
of all obligations arising under such provision, but only to the extent that it is illegal, unenforceable or void, it being the
intent and agreement of the parties that this Agreement shall be deemed amended by modifying such provision to the extent necessary
to make it legal and enforceable while preserving its intent or, if that is not possible, by substituting therefor another provision
that is legal and enforceable and achieves the same objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(f) <U>Interpretation</U>. All section titles
and captions in this Agreement are for convenience only, shall not be deemed part of this Agreement, and in no way shall define,
limit, extend or describe the scope or intent of any provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(g) <U>Entire Agreement</U>. This Agreement constitutes
the entire agreement among the parties hereto pertaining to the subject matter hereof and supersedes all prior agreements and understandings
pertaining thereto.</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(h) <U>No Waiver</U>. No failure by any party
to insist upon the strict performance of any covenant, duty, agreement or condition of this Agreement or to exercise any right
or remedy consequent upon a breach thereof shall constitute waiver of any such breach or any other covenant, duty, agreement or
condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt"><FONT STYLE="color: black">(i) </FONT><U>Section
409A of the Code</U>. This Agreement is intended to comply with the requirements of Section 409A of the Code or an exemption or
exclusion therefrom and, with respect to amounts that <FONT STYLE="color: black">are</FONT> subject to Section 409A of the Code,
it is intended that this Agreement be administered in all respects in accordance with Section 409A of the Code. In no event may
you, directly or indirectly, designate the calendar year of any payment to be made under this Agreement that constitutes non-qualified
deferred compensation subject to Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt"><FONT STYLE="color: black">(j) <U>Data Privacy</U>.
You understand that the Company and the Company subsidiary for which you work may hold certain </FONT>personal<FONT STYLE="color: black">
information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance
number or other identification number, any Shares or directorships held in the Company, details of all PBRSUs. By accepting the
PBRSUs, you explicitly and unambiguously consent to the collection, use, transfer, holding, storage and disclosure in electronic
or other form, of your personal data as described in this Agreement and any other Award grant materials (&ldquo;<U>Data</U>&rdquo;)
by and among, as applicable, the Company, its subsidiaries and Affiliates (collectively referred to in this Data Privacy section
as the &ldquo;<U>Company</U>&rdquo;) and certain third party service providers including, but not limited to, Plan brokers, financial
advisers and legal counsel, engaged by the Company (collectively, the &ldquo;<U>Providers</U>&rdquo;) for the purpose of implementing,
administering and managing the Plan and complying with applicable laws, regulations and legislation. You understand that the Data
which may be collected, used, transferred, held, stored or disclosed by the Company and the Providers consists of certain Data
about you, including, but not limited to, your name, home address, telephone number, date of birth, social insurance number or
other government identification number, salary, nationality, job title, any Shares or directorships held in the Company, details
of all PBRSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor. The
Data may also include information relating to your health (for example, where your employment terminates due to death or Disability).
You further understand that such collection, use, transfer, holding, storage or disclosure of the Data may be necessary for the
purpose of implementing, administering and managing the Plan and complying with applicable laws, regulations and legislation. You
understand that the Company or the Providers may be located in the United States or elsewhere, and that the laws of the country
in which the Company and the Providers collect, use, transfer, hold, store or disclose the Data may have different legal protections
for the Data than your country. However, regardless of the location of the Data, the Company protects the Data through reasonable
physical, technical and administrative safeguards and requires that the Providers also have such safeguards in place. You understand
that you may, at any time, request a copy of your Data, request additional information about the storage and processing of Data,
require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting your
local human resources representative in writing. You understand that refusing or withdrawing your consent may affect your ability
to participate in the Plan as more fully described below. You understand that you are providing the consent herein on a purely
voluntary basis. If you do not consent, or if you later seek to revoke your consent, your </FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">employment status or service and career with your employer will
not be adversely affected; the only adverse consequence of refusing or withdrawing your consent is that the Company would not be
able to grant PBRSUs or other equity awards or administer or maintain such awards. Therefore, you understand that refusing or withdrawing
your consent may affect your ability to participate in the Plan. For more information on the consequences of your refusal to consent
or withdrawal of consent, you understand that you may contact your local human resources representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">(k) <U>Counterparts</U>. This Agreement may be
executed in counterparts, all of which together shall constitute one agreement binding on all the parties hereto, notwithstanding
that all such parties are not signatories to the original or the same counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 72pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 50%"><FONT STYLE="color: black">COLGATE-PALMOLIVE COMPANY</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-bottom: 1px">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px; border-bottom: Black 1px solid">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="color: black">Authorized Signature</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 216pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Using the Merrill BenefitsOnline system or other available means,
you must accept the above PBRSUs in accordance with and subject to the terms and conditions of this Agreement and the Plan, acknowledge
that you have read this Agreement and the Plan, and agree to be bound by this Agreement, the Plan and the actions of the Committee.
If you do not do so prior to the Certification Date, then the Company may declare the Award null and void at any time.</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[Intentionally Left Blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
